OS Therapies names Kerry Clem chief commercial officer

Bitget2026/10/05 20:38

OS Therapies named Kerry Clem chief commercial officer to lead launch planning for Herlystic across the U.S., U.K., Europe. Clem previously served as CEO of Solaxa, chief commercial officer at Acorda Therapeutics, held commercial leadership roles at Allos Therapeutics. Frank Knuettel II was appointed chief financial officer as the company prepares to transition toward commercialization. Knuettel most recently served as CFO of Pelthos Therapeutics, previously CEO of Channel Therapeutics, led more than 15 M&A deals. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OS Therapies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-106849), on October 05, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Copper prices approach historic highs! UBS remains bullish: "Still most optimistic"

华尔街见闻•2026/10/11 01:57

A COVID Vaccine Stock on the S&P 500 Is Up 600% This Year

BeInCrypto•2026/10/10 22:48

The number of stablecoin holders on the Solana chain has surpassed 14 million.

AiCoin•2026/10/10 21:35

Cathie Wood’s ARK Sells Bitcoin ETF, SpaceX and Robinhood Shares in Portfolio Shift

CoinEdition•2026/10/10 17:39